Gujarat Themis Biosyn Limited (BSE: 506879)
Health Care · Pharmaceuticals · IN
Rs363.25
-5.00% today · -13.8% 1Y
Gujarat Themis Biosyn Limited (BSE: 506879) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $488.50M.
Over the last twelve months the share price has lost 13.8%, trading between 225.75 and 479.45.
Tweenvest scores Gujarat Themis Biosyn Limited across four factors: quality 73/100, value 20/100, growth 45/100, dividend 39/100. Its strongest factor is quality.
506879 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $488.50M
- Revenue (TTM)
- $18.38M
- P/E
- 81.25
- EPS
- 4.47
- Dividend yield
- 0.18%
- Beta (5Y)
- 0.64
- 52-week high
- Rs479.45
- 52-week low
- Rs225.75
- Avg volume (3M)
- —
- Shares outstanding
- 130.15M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tong Ren Tang Technologies Co. Ltd.SEHK: 1666 | $496.97M | HK$3.05 | -0.33% |
| YungShin Global Holding CorporationTWSE: 3705 | $492.33M | NT$59.10 | +4.97% |
| Daewoong Co., Ltd.KOSE: A003090 | $490.60M | ₩15,690.00 | +2.28% |
| Zhejiang Haisen Pharmaceutical Co., Ltd.SZSE: 001367 | $488.63M | CN¥21.77 | -1.09% |
| Clarity Pharmaceuticals LtdASX: CU6 | $480.35M | AU$1.85 | -12.14% |
| Zhejiang East Asia Pharmaceutical Co., Ltd.SHSE: 605177 | $475.37M | CN¥28.29 | +16.61% |
| Hinova Pharmaceuticals Inc.SHSE: 688302 | $474.37M | CN¥32.09 | -3.75% |
| Zota Health Care LimitedNSEI: ZOTA | $473.82M | Rs1,324.10 | +4.44% |
Figures last refreshed Oct 11, 2026.